Jafron Biomedical Profit Margin vs. Current Valuation
| 300529 Stock | 30.48 0.41 1.36% |
For Jafron Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Jafron Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Jafron Biomedical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Jafron Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Jafron Biomedical Co over time as well as its relative position and ranking within its peers.
Jafron |
Jafron Biomedical Current Valuation vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Jafron Biomedical's current stock value. Our valuation model uses many indicators to compare Jafron Biomedical value to that of its competitors to determine the firm's financial worth. Jafron Biomedical Co is number one stock in profit margin category among its peers. It also is the top company in current valuation category among its peers reporting about 76,064,225,903 of Current Valuation per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Jafron Biomedical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Jafron Biomedical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Jafron Current Valuation vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Jafron Biomedical |
| = | 0.31 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Jafron Biomedical |
| = | 23.25 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Jafron Current Valuation vs Competition
Jafron Biomedical Co is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 45.75 Billion. Jafron Biomedical totals roughly 23.25 Billion in current valuation claiming about 51% of equities under Health Care industry.
Jafron Biomedical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Jafron Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Jafron Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Jafron Biomedical's change in net profit over the period of time. It can combine multiple indicators of Jafron Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 523.2 M | 528.6 M | |
| Income Before Tax | 521 M | 549.8 M | |
| Income Tax Expense | 243.1 M | 255.2 M | |
| Net Income From Continuing Ops | 425.7 M | 615 M | |
| Total Other Income Expense Net | -10.5 M | -10 M | |
| Net Income Applicable To Common Shares | 1.4 B | 1.4 B | |
| Net Income | 436.5 M | 618.2 M | |
| Net Interest Income | 32.7 M | 34.3 M | |
| Interest Income | 88 M | 92.4 M | |
| Change To Netincome | -12.7 M | -13.3 M |
Jafron Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Jafron Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Jafron Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Jafron Biomedical's important profitability drivers and their relationship over time.
Use Jafron Biomedical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jafron Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jafron Biomedical will appreciate offsetting losses from the drop in the long position's value.Jafron Biomedical Pair Trading
Jafron Biomedical Co Pair Trading Analysis
The ability to find closely correlated positions to Jafron Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jafron Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jafron Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jafron Biomedical Co to buy it.
The correlation of Jafron Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jafron Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jafron Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jafron Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Jafron Biomedical position
In addition to having Jafron Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Books Thematic Idea Now
Books
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Jafron Stock
To fully project Jafron Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Jafron Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Jafron Biomedical's income statement, its balance sheet, and the statement of cash flows.